Julian Adams

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.

Stand Up To Cancer (SU2C) is a non-profit organization that raises funds to accelerate cancer research and bring new therapies to patients quickly. SU2C is based in Los Angeles, CA. Established in 2008 by media and entertainment leaders, SU2C engages the public in supporting a collaborative model of cancer research, increasing awareness about cancer prevention, and highlighting progress in the fight against the disease. The organization has over 3,000 scientists from more than 210 institutions involved in SU2C-funded research projects. The American Association for Cancer Research (AACR) and a scientific advisory committee oversee grants administration and provide expert review of research progress.

Stand Up To Cancer (SU2C) is a non-profit organization that raises funds to accelerate cancer research and bring new therapies to patients quickly. SU2C is based in Los Angeles, CA. Established in 2008 by media and entertainment leaders, SU2C engages the public in supporting a collaborative model of cancer research, increasing awareness about cancer prevention, and highlighting progress in the fight against the disease. The organization has over 3,000 scientists from more than 210 institutions involved in SU2C-funded research projects. The American Association for Cancer Research (AACR) and a scientific advisory committee oversee grants administration and provide expert review of research progress.